Merck Animal Health

Corporate brand

Merck Animal Health is a research-driven animal health business whose mission is 'The Science of Healthier Animals,' offering vaccines, therapeutic medicines, parasiticides, and technology solutions for companion animals and livestock.

Last updated October 17, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Merck Animal Health describes its mission as 'The Science of Healthier Animals.' It states that it is committed to protecting the health of animals and supporting a safe and affordable food supply, and that through a broad portfolio of vaccines, therapeutic medicines, parasiticides, and technology solutions it helps veterinarians, pet owners, farmers, and producers maintain and improve the health of animals. Its product areas span companion animals, ruminants, poultry, swine, aqua, and equine. The company states that for over 130 years Merck has been a global leader in groundbreaking science, and that today it develops medicines, vaccines and technology that improve the health and well-being of animals worldwide. Merck Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species. It markets products in more than 150 countries with offices in more than 50 countries, and operates a network of manufacturing sites and R&D facilities. Its story began in the Netherlands in the 1940s with sulfaquinoxaline, the first poultry coccidiostat, and it now has headquarters in Madison, New Jersey, USA.

History

Merck Animal Health states that for over 130 years Merck has been a global leader in groundbreaking science, and that today it develops breakthrough medicines, vaccines and technology that improve the health and well-being of animals worldwide. It describes its team as including veterinarians, farmers and caregivers, and says it works closely with customers on the farm, in the clinic, or in the field. Its stated focus is to empower those who care for animals with tools and confidence, from advanced vaccine solutions for companion animals to real-time monitoring and breakthrough treatments for livestock. The company presents a timeline of a 'Legacy of Innovation' spanning the 1940s through the 2020s, including a 2020s item noting that Merck Animal Health received a CVMP positive opinion for INNOVAX®-ND-ILT in the European Union. Merck Animal Health states that its story began in the Netherlands in the 1940s, with sulfaquinoxaline as its original product, described as the first poultry coccidiostat. The company evolved and merged throughout the decades while maintaining a commitment to collaborating and building partnerships to improve animal health worldwide. It now operates in 150 countries with headquarters in Madison, New Jersey, USA.

New data on BOVILIS® NASALGEN®-C intranasal vaccination against bovine coronavirus
[1]Homepage - Merck Animal Healthmerck-animal-health.com
FDA approval of BRAVECTO® QUANTUM
[1]Homepage - Merck Animal Healthmerck-animal-health.com

Products and positioning

Animal health business focused on 'The Science of Healthier Animals,' serving veterinarians, pet owners, farmers, and producers. Aims to be the partner of choice for veterinarians, producers and animal owners by providing innovative, high-quality, solutions-driven products and services. Animal health business focused on 'The Science of Healthier Animals,' serving veterinarians, pet owners, farmers, and producers, and aiming to be the partner of choice for veterinarians, producers and animal owners by providing innovative, high-quality, solutions-driven products and services.

BOVILIS® NASALGEN®-C
Lyophilisate and solvent for suspension for cattle, used for intranasal vaccination against bovine coronavirus.
BRAVECTO® QUANTUM
Fluralaner for extended-release injectable suspension; a new, innovative formulation of a trusted active ingredient for companion animals.
INNOVAX®-ND-ILT
Received a CVMP positive opinion in the European Union.
Mometamax Single™
A convenient single-dose, in-clinic treatment for canine otitis externa with a novel combination of active ingredients.
SEQUIVITY™ Technology
A flexible, rapid and targeted vaccine production platform incorporating immuno-precision capabilities that protects against a wide range of disease-causing viral and bacterial pathogens in food producing livestock and companion animals.

Recent events

2021.11.02
Reported2021.11.02
VETIGENICS and Merck Animal Health extend discovery collaboration[9]VETIGENICS与默克动物保健延长发现合作prnewswire.com
VETIGENICS announced an extension of its discovery collaboration with Merck Animal Health to use the CANIBODY Platform to discover and develop therapeutic antibodies for chronic diseases in companion animals.
2021.05.12
Reported2021.05.12
ALSS secures initial close of $7 million Series B financing[10]ALSS完成700万美元B轮融资首轮交割prnewswire.com
Applied LifeSciences & Systems announced the initial close of a $7 million Series B equity financing, co-led by Merck Animal Health and Mountain Group Partners, with Oval Park Capital also participating.
2021.02.25
Reported2021.02.25
Merck Animal Health completes acquisition of Poultry Sense[11]默克动物保健完成收购 Poultry Senseinvestingnews.com
Merck Animal Health announced that it had completed its acquisition of PrognostiX Poultry Limited, doing business as Poultry Sense Ltd., from its founding shareholders. The acquisition adds poultry health and environmental monitoring technology to its portfolio.
Unconfirmed
Reported2020.07.05
Merck Animal Health completes acquisition of U.S. rights to SENTINEL products[12]默克动物保健完成收购 SENTINEL 产品美国权利medicaldialogues.in
Merck Animal Health completed its acquisition from Virbac of the U.S. rights to SENTINEL FLAVOR TABS and SENTINEL SPECTRUM Chews.

Sources12 sources

Cite this profile: Cite the canonical profile. /brand-wiki/merck-animal-health · Editorial policy · How profiles are compiled